URS
SRPT icon

Utah Retirement Systems’s Sarepta Therapeutics SRPT Stock Holding History

Utah Retirement Systems’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-14,971
Closed -$256K – 1010
2025
Q2 		$256K Hold
14,971
– – ﹤0.01% 925
2025
Q1 		$955K Hold
14,971
– – 0.01% 696
2024
Q4 		$1.82M Hold
14,971
– – 0.02% 577
2024
Q3 		$1.87M Buy
14,971
+100
+0.7% +$13.8K 0.02% 577
2024
Q2 		$2.35M Sell
14,871
-500
-3% -$64.2K 0.03% 496
2024
Q1 		$1.99M Sell
15,371
-100
-0.6% -$12.3K 0.02% 563
2023
Q4 		$1.49M Buy
15,471
+100
+0.7% +$9.59K 0.02% 638
2023
Q3 		$1.86M Buy
15,371
+100
+0.7% +$11.3K 0.03% 540
2023
Q2 		$1.75M Buy
15,271
+200
+1% +$25.8K 0.02% 573
2023
Q1 		$2.08M Buy
15,071
+100
+0.7% +$13K 0.03% 518
2022
Q4 		$1.94M Hold
14,971
– – 0.03% 502
2022
Q3 		$1.65M Buy
14,971
+100
+0.7% +$10.1K 0.03% 539
2022
Q2 		$1.11M Hold
14,871
– – 0.02% 673
2022
Q1 		$1.16M Sell
14,871
-300
-2% -$23K 0.02% 723
2021
Q4 		$1.37M Buy
15,171
+1,300
+9% +$111K 0.02% 700
2021
Q3 		$1.28M Sell
13,871
-600
-4% -$46.2K 0.02% 722
2021
Q2 		$1.13M Hold
14,471
– – 0.01% 768
2021
Q1 		$1.08M Sell
14,471
-600
-4% -$55.4K 0.02% 760
2020
Q4 		$2.57M Buy
15,071
+800
+6% +$119K 0.04% 467
2020
Q3 		$2M Buy
14,271
+100
+0.7% +$15.2K 0.03% 485
2020
Q2 		$2.27M Buy
14,171
+700
+5% +$95.3K 0.04% 401
2020
Q1 		$1.32M Hold
13,471
– – 0.03% 508
2019
Q4 		$1.74M Hold
13,471
– – 0.03% 543
2019
Q3 		$1.01M Buy
13,471
+300
+2% +$35.4K 0.02% 705
2019
Q2 		$2M Buy
13,171
+675
+5% +$82K 0.04% 470
2019
Q1 		$1.49M Buy
12,496
+196
+2% +$25.2K 0.03% 559
2018
Q4 		$1.34M Buy
12,300
+700
+6% +$87.5K 0.03% 542
2018
Q3 		$1.87M Buy
11,600
+100
+0.9% +$13.7K 0.04% 484
2018
Q2 		$1.52M Buy
+11,500
New +$1.08M 0.03% 547

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Utah Retirement Systems's SRPT Position: Q3 2025 in Review

Utah Retirement Systems sold out of Sarepta Therapeutics (SRPT) in Q3 2025, closing a stake of 14,971 shares — an estimated $256K sold.

Utah Retirement Systems first reported a position in SRPT in Q2 2018 and held it in 29 quarters. The position peaked at $2.57M in Q4 2020. 319 funds tracked by Wall St. Rank hold SRPT as of Q3 2025.

  • Utah Retirement Systems reported no remaining Sarepta Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Utah Retirement Systems sold 14,971 Sarepta Therapeutics shares in Q3 2025, an estimated $256K.
  • Utah Retirement Systems first reported a position in Sarepta Therapeutics in Q2 2018 and held it in 29 quarters.
  • Utah Retirement Systems's Sarepta Therapeutics position peaked at $2.57M in Q4 2020.
  • 319 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2025.

Based on Utah Retirement Systems's 13F filing for Q3 2025, filed 14 Nov 2025.